These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33613327)

  • 1. Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond.
    Bhusal A; Lee WH; Suk K
    Front Physiol; 2021; 12():638112. PubMed ID: 33613327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress on Lipocalin-2 in Diabetic Encephalopathy.
    Zhang W; Chen S; Zhuang X
    Neuroscience; 2023 Apr; 515():74-82. PubMed ID: 36805002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical role of lipocalin-2 in metabolic disorders and neurological complications.
    Bhusal A; Rahman MH; Lee WH; Bae YC; Lee IK; Suk K
    Biochem Pharmacol; 2019 Nov; 169():113626. PubMed ID: 31476294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.
    Lim D; Jeong JH; Song J
    CNS Neurosci Ther; 2021 Aug; 27(8):883-894. PubMed ID: 33945675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response.
    Nairz M; Schroll A; Haschka D; Dichtl S; Sonnweber T; Theurl I; Theurl M; Lindner E; Demetz E; Aßhoff M; Bellmann-Weiler R; Müller R; Gerner RR; Moschen AR; Baumgartner N; Moser PL; Talasz H; Tilg H; Fang FC; Weiss G
    Eur J Immunol; 2015 Nov; 45(11):3073-86. PubMed ID: 26332507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse functional roles of lipocalin-2 in the central nervous system.
    Jha MK; Lee S; Park DH; Kook H; Park KG; Lee IK; Suk K
    Neurosci Biobehav Rev; 2015 Feb; 49():135-56. PubMed ID: 25511817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.
    Abella V; Scotece M; Conde J; Gómez R; Lois A; Pino J; Gómez-Reino JJ; Lago F; Mobasheri A; Gualillo O
    Biomarkers; 2015; 20(8):565-71. PubMed ID: 26671823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin 2 receptors: facts, fictions, and myths.
    Schröder SK; Gasterich N; Weiskirchen S; Weiskirchen R
    Front Immunol; 2023; 14():1229885. PubMed ID: 37638032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin 2 Protects Against
    Wang Q; Li S; Tang X; Liang L; Wang F; Du H
    Front Immunol; 2019; 10():2594. PubMed ID: 31781104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis.
    Asimakopoulou A; Fülöp A; Borkham-Kamphorst E; de Leur EV; Gassler N; Berger T; Beine B; Meyer HE; Mak TW; Hopf C; Henkel C; Weiskirchen R
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2093-2110. PubMed ID: 28396286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy.
    Asimakopoulou A; Weiskirchen S; Weiskirchen R
    Front Physiol; 2016; 7():430. PubMed ID: 27729871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.
    Steigedal M; Marstad A; Haug M; Damås JK; Strong RK; Roberts PL; Himpsl SD; Stapleton A; Hooton TM; Mobley HL; Hawn TR; Flo TH
    J Immunol; 2014 Dec; 193(12):6081-9. PubMed ID: 25398327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective.
    Suk K
    Prog Neurobiol; 2016 Sep; 144():158-72. PubMed ID: 27498195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the periphery to the brain: Lipocalin-2, a friend or foe?
    Ferreira AC; Dá Mesquita S; Sousa JC; Correia-Neves M; Sousa N; Palha JA; Marques F
    Prog Neurobiol; 2015 Aug; 131():120-36. PubMed ID: 26159707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis.
    Jung BK; Ryu KY
    Exp Mol Med; 2023 Oct; 55(10):2138-2146. PubMed ID: 37779143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy.
    Bhusal A; Rahman MH; Lee IK; Suk K
    Front Endocrinol (Lausanne); 2019; 10():25. PubMed ID: 30761088
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Borkham-Kamphorst E; Van de Leur E; Meurer SK; Buhl EM; Weiskirchen R
    Front Pharmacol; 2018; 9():426. PubMed ID: 29755357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
    Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
    J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms.
    Wu L; Du Y; Lok J; Lo EH; Xing C
    J Neurochem; 2015 Mar; 132(6):622-8. PubMed ID: 25557118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells.
    Miharada K; Hiroyama T; Sudo K; Danjo I; Nagasawa T; Nakamura Y
    J Cell Physiol; 2008 May; 215(2):526-37. PubMed ID: 18064607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.